{{Rsnum
|rsid=2186944
|Gene=MC2R
|Chromosome=18
|position=13915543
|Orientation=plus
|GMAF=0.07622
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MC2R
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.9 | 99.1
| HCB | 3.8 | 27.5 | 68.7
| JPT | 0.0 | 17.1 | 82.9
| YRI | 2.1 | 22.6 | 75.3
| ASW | 0.0 | 17.9 | 82.1
| CHB | 3.8 | 27.5 | 68.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 4.0 | 96.0
| LWK | 0.9 | 5.5 | 93.6
| MEX | 0.0 | 13.8 | 86.2
| MKK | 0.0 | 11.6 | 88.4
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|19024088}} [[rs1893220]] and [[rs2186944]] efficacy of ACTH therapy on infantile spasms.

{{PMID Auto
|PMID=20042918
|Title=ACTH receptor (MC2R) promoter variants associated with infantile spasms modulate MC2R expression and responsiveness to ACTH
}}

{{PMID Auto
|PMID=18359160
|Title=Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}